Tikhonov Denis B, Zhorov Boris S
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.
J Biol Chem. 2009 Jul 10;284(28):19006-17. doi: 10.1074/jbc.M109.011296. Epub 2009 May 5.
1,4-Dihydropyridines (DHPs) constitute a major class of ligands for L-type Ca(2+) channels (LTCC). The DHPs have a boat-like, six-membered ring with an NH group at the stern, an aromatic moiety at the bow, and substituents at the port and starboard sides. Various DHPs exhibit antagonistic or agonistic activities, which were previously explained as stabilization or destabilization, respectively, of the closed activation gate by the portside substituents. Here we report a novel structural model in which agonist and antagonist activities are determined by different parts of the DHP molecule and have different mechanisms. In our model, which is based on Monte Carlo minimizations of DHP-LTCC complexes, the DHP moieties at the stern, bow, and starboard form H-bonds with side chains of the key DHP-sensing residues Tyr_IIIS6, Tyr_IVS6, and Gln_IIIS5, respectively. We propose that these H-bonds, which are common for agonists and antagonists, stabilize the LTCC conformation with the open activation gate. This explains why both agonists and antagonists increase probability of the long lasting channel openings and why even partial disruption of the contacts eliminates the agonistic action. In our model, the portside approaches the selectivity filter. Hydrophobic portside of antagonists may induce long lasting channel closings by destabilizing Ca(2+) binding to the selectivity filter glutamates. Agonists have either hydrophilic substituents or a hydrogen atom at their portside, and thus lack this destabilizing effect. The predicted orientation of the DHP core allows accommodation of long substituents in the domain interface or in the inner pore. Our model may be useful for developing novel clinically relevant LTCC blockers.
1,4-二氢吡啶(DHPs)是L型钙通道(LTCC)的一类主要配体。DHPs具有船型六元环,环尾有一个NH基团,船头有一个芳香部分,左右两侧有取代基。各种DHPs表现出拮抗或激动活性,以前分别解释为环左侧取代基对关闭的激活门的稳定或去稳定作用。在此,我们报告一种新的结构模型,其中激动剂和拮抗剂活性由DHP分子的不同部分决定,且具有不同机制。在我们基于DHP-LTCC复合物蒙特卡罗最小化的模型中,环尾、船头和右侧的DHP部分分别与关键的DHP感知残基Tyr_IIIS6、Tyr_IVS6和Gln_IIIS5的侧链形成氢键。我们提出,这些激动剂和拮抗剂共有的氢键稳定了具有开放激活门的LTCC构象。这解释了为什么激动剂和拮抗剂都增加了长时程通道开放的概率,以及为什么即使部分接触破坏也会消除激动作用。在我们的模型中,环左侧靠近选择性过滤器。拮抗剂的疏水环左侧可能通过破坏Ca(2+)与选择性过滤器谷氨酸的结合而诱导长时程通道关闭。激动剂在其环左侧具有亲水取代基或氢原子,因此缺乏这种去稳定作用。DHP核心的预测取向允许长取代基容纳在结构域界面或内孔中。我们的模型可能有助于开发新型临床相关的LTCC阻滞剂。